Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease
出版年份 2018 全文链接
标题
Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease
作者
关键词
Anti-TNF therapy, Crohn’s disease, Ulcerative colitis, Antibodies to adalimumab, Therapeutic drug monitoring
出版物
DIGESTIVE DISEASES AND SCIENCES
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-07-13
DOI
10.1007/s10620-018-5202-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Letter: infliximab concentrations during induction therapy-one size does not fit all
- (2018) K. Papamichael et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease
- (2018) Kenji Watanabe et al. Clinical Gastroenterology and Hepatology
- Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice
- (2017) Mariam Aguas Peris et al. INFLAMMATORY BOWEL DISEASES
- Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2016) Bella Ungar et al. Clinical Gastroenterology and Hepatology
- Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis
- (2016) Konstantinos Papamichael et al. Clinical Gastroenterology and Hepatology
- Efficacy and Safety Profile of Anti–tumor Necrosis Factor-α Versus Anti-integrin Agents for the Treatment of Crohn’s Disease: A Network Meta-analysis of Indirect Comparisons
- (2016) Michael Miligkos et al. CLINICAL THERAPEUTICS
- Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohnʼs Disease and Ulcerative Colitis
- (2016) Andres J. Yarur et al. INFLAMMATORY BOWEL DISEASES
- Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis
- (2016) Konstantinos Papamichael et al. Journal of Crohns & Colitis
- Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn’s Disease
- (2016) E. Zittan et al. Journal of Crohns & Colitis
- Higher Adalimumab Drug Levels Are Associated with Mucosal Healing in Patients with Crohn’s Disease
- (2016) Konstantinos Papamichael et al. Journal of Crohns & Colitis
- Association between serum adalimumab concentrations and endoscopic disease activity in patients with Crohn's disease
- (2016) Yukihiro Morita et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Prediction of clinical and endoscopic responses to anti-tumor necrosis factor-α antibodies in ulcerative colitis
- (2016) Yukihiro Morita et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
- (2015) L Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
- (2015) Johannan F. Brandse et al. GASTROENTEROLOGY
- Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis
- (2014) F. Baert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease
- (2014) Y. Mazor et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
- (2014) Xavier Roblin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Proactive Therapeutic Concentration Monitoring of Infliximab May Improve Outcomes for Patients with Inflammatory Bowel Disease
- (2014) Byron P. Vaughn et al. INFLAMMATORY BOWEL DISEASES
- Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases
- (2013) Xavier Roblin et al. Clinical Gastroenterology and Hepatology
- Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay
- (2013) Shui-Long Wang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started